PFBT
HLVX

Parkside Financial Bank & Trust’s HilleVax HLVX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-285
Closed -$411 – 2856
2025
Q1 		$411 Buy
+285
New +$527 ﹤0.01% 2527

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
LMC
Lightspeed Management Company Menlo Park, California $988M AUM 7.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Parkside Financial Bank & Trust's HLVX Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of HilleVax (HLVX) in Q2 2025, closing a stake of 285 shares — an estimated $411 sold.

Parkside Financial Bank & Trust first reported a position in HLVX in Q1 2025 and held it in 1 quarter. The position peaked at $411 in Q1 2025. 74 funds tracked by Wall St. Rank hold HLVX as of Q2 2025.

  • Parkside Financial Bank & Trust reported no remaining HilleVax position as of Q2 2025 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 285 HilleVax shares in Q2 2025, an estimated $411.
  • Parkside Financial Bank & Trust first reported a position in HilleVax in Q1 2025 and held it in 1 quarter.
  • Parkside Financial Bank & Trust's HilleVax position peaked at $411 in Q1 2025.
  • 74 funds tracked by Wall St. Rank held HilleVax as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.